neovascular glaucoma

Summary

Summary: A form of secondary glaucoma which develops as a consequence of another ocular disease and is attributed to the forming of new vessels in the angle of the anterior chamber.

Top Publications

  1. Iliev M, Domig D, Wolf Schnurrbursch U, Wolf S, Sarra G. Intravitreal bevacizumab (Avastin) in the treatment of neovascular glaucoma. Am J Ophthalmol. 2006;142:1054-6 pubmed
    To describe a case series of neovascular glaucoma (NVG) caused by central retinal vein occlusion (CRVO) that was treated with intravitreal bevacizumab (IVB; Avastin). Retrospective interventional case series...
  2. Yalvac I, Eksioglu U, Satana B, Duman S. Long-term results of Ahmed glaucoma valve and Molteno implant in neovascular glaucoma. Eye (Lond). 2007;21:65-70 pubmed
    ..surgical success results of Ahmed glaucoma valve (AGV) and Molteno single-plate implant (MSPI) in cases of neovascular glaucoma (NVG)...
  3. Mandal A, Majji A, Mandal S, Das T, Jalali S, Gothwal V, et al. Mitomycin-C-augmented trabeculectomy for neovascular glaucoma. A preliminary report. Indian J Ophthalmol. 2002;50:287-93 pubmed
    This study aimed to investigate the safety and efficacy of trabeculectomy with intraoperative mitomycin C (MMC) in the management of eyes with neovascular glaucoma (NVG).
  4. Chalam K, Gupta S, Grover S, Brar V, Agarwal S. Intracameral Avastin dramatically resolves iris neovascularization and reverses neovascular glaucoma. Eur J Ophthalmol. 2008;18:255-62 pubmed
    ..To report the biologic effect of intracameral bevacizumab in patients with iris neovascularization secondary to proliferative retinal vasculopathies...
  5. Blanc J, Molteno A, Fuller J, Bevin T, Herbison P. Life expectancy of patients with neovascular glaucoma drained by Molteno implants. Clin Exp Ophthalmol. 2004;32:360-3 pubmed
    To determine the survival of patients with sighted eyes who had Molteno implants inserted for neovascular glaucoma.
  6. Yildirim N, Yalvac I, Sahin A, Ozer A, Bozca T. A comparative study between diode laser cyclophotocoagulation and the Ahmed glaucoma valve implant in neovascular glaucoma: a long-term follow-up. J Glaucoma. 2009;18:192-6 pubmed publisher
    To compare the efficacy, safety, and long-term results of intraocular pressure (IOP) reduction by diode laser contact cyclophotocoagulation (DCPC) and Ahmed glaucoma valve (AGV) implant in cases of neovascular glaucoma.
  7. Kiuchi Y, Nakae K, Saito Y, Ito S, Ito N. Pars plana vitrectomy and panretinal photocoagulation combined with trabeculectomy for successful treatment of neovascular glaucoma. Graefes Arch Clin Exp Ophthalmol. 2006;244:1627-32 pubmed
    Treatment of neovascular glaucoma (NVG) must be focused on the reduction of intraocular pressure (IOP) and prompt application of pan retinal photocoagulation (PRP)...
  8. Lee S, Lee J, Kim S, Kim S. Intravitreal bevacizumab (Avastin) treatment of neovascular glaucoma in ocular ischemic syndrome. Korean J Ophthalmol. 2009;23:132-4 pubmed publisher
    We report a case of ocular ischemic syndrome accompanied by neovascular glaucoma that was successfully treated with Bevacizumab...
  9. Duch S, Buchacra O, Milla E, Andreu D, Tellez J. Intracameral bevacizumab (Avastin) for neovascular glaucoma: a pilot study in 6 patients. J Glaucoma. 2009;18:140-3 pubmed publisher
    To describe the use of intracameral bevacizumab (ICB) Avastin in neovascular glaucoma (NVG) as the first maneuver before pan retinal photocoagulation and/or filtering surgery.

More Information

Publications64

  1. Matsui N, Kamao T, Azumi A. [Case of metastatic intraocular malignant lymphoma with neovascular glaucoma]. Nippon Ganka Gakkai Zasshi. 2005;109:434-9 pubmed
    It is relatively rare to encounter a case of neovascular glaucoma induced by malignant lymphoma metastasized into the eyeball.
  2. Löffler K. [Neovascular glaucoma: aetiology, pathogenesis and treatment]. Ophthalmologe. 2006;103:1057-63; quiz 1064 pubmed
    b>Neovascular glaucoma, as a typical secondary glaucoma, is due to ocular or (earlier) systemic diseases...
  3. Kiuchi Y, Sugimoto R, Nakae K, Saito Y, Ito S. Trabeculectomy with mitomycin C for treatment of neovascular glaucoma in diabetic patients. Ophthalmologica. 2006;220:383-8 pubmed
    To assess the efficacy and to determine the risk factors of trabeculectomy with mitomycin C (MMC) in eyes with neovascular glaucoma (NVG) secondary to diabetic retinopathy.
  4. Bianciotto C, Shields C, Kang B, Shields J. Treatment of iris melanoma and secondary neovascular glaucoma using bevacizumab and plaque radiotherapy. Arch Ophthalmol. 2008;126:578-9 pubmed publisher
  5. Danias J, Rosenbaum J, Podos S. Diffuse retinal hemorrhages (ocular decompression syndrome) after trabeculectomy with mitomycin C for neovascular glaucoma. Acta Ophthalmol Scand. 2000;78:468-9 pubmed
    To describe a case of ocular decompression syndrome in a patient after trabeculectomy with mitomycin C for neovascular glaucoma.
  6. Wakabayashi T, Oshima Y, Sakaguchi H, Ikuno Y, Miki A, Gomi F, et al. Intravitreal bevacizumab to treat iris neovascularization and neovascular glaucoma secondary to ischemic retinal diseases in 41 consecutive cases. Ophthalmology. 2008;115:1571-80, 1580.e1-3 pubmed publisher
    To evaluate the biologic efficacy of intravitreal bevacizumab (IVB) for iris neovascularization (INV) or neovascular glaucoma (NVG) in patients with ischemic retinal disorders.
  7. Vatavuk Z, Bencic G, Mandic Z. Intravitreal bevacizumab for neovascular glaucoma following central retinal artery occlusion. Eur J Ophthalmol. 2007;17:269-71 pubmed
    To report a case of neovascular glaucoma due to central retinal artery occlusion treated with a single intravitreal injection of bevacizumab.
  8. Elgin U, Berker N, Batman A, Simsek T, Cankaya B. Trabeculectomy with mitomycin C combined with direct cauterization of peripheral iris in the management of neovascular glaucoma. J Glaucoma. 2006;15:466-70 pubmed
    ..C (MMC) combined with direct cauterization of peripheral iris before iridectomy in the management of neovascular glaucoma (NVG), and to demonstrate the effect of this surgical technique on decreasing the incidence of ..
  9. Shazly T, Latina M. Neovascular glaucoma: etiology, diagnosis and prognosis. Semin Ophthalmol. 2009;24:113-21 pubmed publisher
    b>Neovascular glaucoma (NVG) is a severe form of glaucoma with devastating visual outcome attributed to new blood vessels obstructing aqueous humor outflow, usually secondary to widespread posterior segment ischemia...
  10. Silva Paula J, Jorge R, Alves Costa R, Rodrigues M, Scott I. Short-term results of intravitreal bevacizumab (Avastin) on anterior segment neovascularization in neovascular glaucoma. Acta Ophthalmol Scand. 2006;84:556-7 pubmed
  11. Hasanreisoglu M, Weinberger D, Mimouni K, Luski M, Bourla D, Kramer M, et al. Intravitreal bevacizumab as an adjunct treatment for neovascular glaucoma. Eur J Ophthalmol. 2009;19:607-12 pubmed
    To assess the effect of adjunctive intravitreal bevacizumab treatment on neovascular glaucoma (NVG).
  12. Andrijevic Derk B, Vatavuk Z, Bencić G, Novak Laus K, Mandic Z. Intravitreal bevacizumab for neovascular glaucoma. Acta Clin Croat. 2008;47:175-9 pubmed
    ..aim of the study was to assess short-term efficacy of intravitreal bevacizumab in a series of patients with neovascular glaucoma. Eleven patients with neovascular glaucoma and symptomatic elevation of intraocular pressure were treated ..
  13. Saito Y, Higashide T, Takeda H, Ohkubo S, Sugiyama K. Beneficial effects of preoperative intravitreal bevacizumab on trabeculectomy outcomes in neovascular glaucoma. Acta Ophthalmol. 2010;88:96-102 pubmed publisher
    This study aimed to investigate the effects of preoperative intravitreal bevacizumab (IVB) on outcomes in trabeculectomy for neovascular glaucoma (NVG).
  14. Hayreh S. Neovascular glaucoma. Prog Retin Eye Res. 2007;26:470-85 pubmed
    b>Neovascular glaucoma (NVG) is a severely blinding, intractable disease. The objective of this review is to provide detailed information on its basic and clinical aspects, to enable us to manage it logically...
  15. Seo M, Woo J, Seo J. Neovascular glaucoma associated with cilioretinal artery occlusion combined with perfused central retinal vein occlusion. Jpn J Ophthalmol. 2002;46:198-202 pubmed
    Cilioretinal artery occlusion rarely results in neovascular glaucoma, especially in cases of extensive cilioretinal infarction and combined retinal vascular occlusion.
  16. Miki A, Oshima Y, Otori Y, Kamei M, Tano Y. Efficacy of intravitreal bevacizumab as adjunctive treatment with pars plana vitrectomy, endolaser photocoagulation, and trabeculectomy for neovascular glaucoma. Br J Ophthalmol. 2008;92:1431-3 pubmed publisher
  17. Chen C, Lai I, Wu P, Chen Y, Chen Y, Lee J, et al. Adjunctive intravitreal bevacizumab-combined trabeculectomy versus trabeculectomy alone in the treatment of neovascular glaucoma. J Ocul Pharmacol Ther. 2010;26:111-8 pubmed publisher
    To evaluate the effect of adjunctive intravitreal bevacizumab (ivBe) with trabeculectomy versus trabeculectomy alone in the management of patients with neovascular glaucoma (NVG).
  18. Song W, Ha S, Yeom H, Seoung G, Hong Y. Recurrent intraocular pressure elevation during hemodialysis in a patient with neovascular glaucoma. Korean J Ophthalmol. 2006;20:109-12 pubmed
    To report a patient with symptomatic intraocular pressure (lOP) elevation in an eye with neovascular glaucoma (NVG) during hemodialysis.
  19. Davidorf F, Mouser J, Derick R. Rapid improvement of rubeosis iridis from a single bevacizumab (Avastin) injection. Retina. 2006;26:354-6 pubmed
  20. Netland P. The Ahmed glaucoma valve in neovascular glaucoma (An AOS Thesis). Trans Am Ophthalmol Soc. 2009;107:325-42 pubmed
    To evaluate the results of Ahmed glaucoma valve surgery in neovascular glaucoma and control patients.
  21. Yu X, Sun X, Dahan E, Guo W, Qian S, Meng F, et al. Increased levels of transforming growth factor-betal and -beta2 in the aqueous humor of patients with neovascular glaucoma. Ophthalmic Surg Lasers Imaging. 2007;38:6-14 pubmed
    To measure the concentrations of transforming growth factor-betal and beta2 (TGF-beta1 and TGF-beta2) in the aqueous humor of patients with neovascular glaucoma (NVG).
  22. Costagliola C, Cipollone U, Rinaldi M, Della Corte M, Semeraro F, Romano M. Intravitreal bevacizumab (Avastin) injection for neovascular glaucoma: a survey on 23 cases throughout 12-month follow-up. Br J Clin Pharmacol. 2008;66:667-73 pubmed publisher
    b>Neovascular glaucoma (NVG) represents one of the most severe forms of secondary glaucoma, caused by a number of ocular and systemic conditions, which share the common element of retinal ischaemia/hypoxia that initiates the subsequent ..
  23. Gheith M, Siam G, de Barros D, Garg S, Moster M. Role of intravitreal bevacizumab in neovascular glaucoma. J Ocul Pharmacol Ther. 2007;23:487-91 pubmed
    We report on the effect of intravitreal bevacizumab (IVB) for the treatment of neovascular glaucoma (NVG). A retrospective chart review of 6 consecutive cases of NVG was performed. The follow-up period was 3-19 months (average, 9...
  24. Kuang T, Liu C, Chou C, Hsu W. Clinical experience in the management of neovascular glaucoma. J Chin Med Assoc. 2004;67:131-5 pubmed
    b>Neovascular glaucoma (NVG) is a devastating ocular disease with poor prognosis. The ideal surgical procedure has yet to be determined...
  25. Sivak Callcott J, O Day D, Gass J, Tsai J. Evidence-based recommendations for the diagnosis and treatment of neovascular glaucoma. Ophthalmology. 2001;108:1767-76; quiz1777, 1800 pubmed
    To succinctly update information on the pathogenesis, etiology, diagnosis, and treatment of neovascular glaucoma based on a systematic review of available literature and to provide summary recommendations rated for their importance to ..
  26. Ehlers J, Spirn M, Lam A, Sivalingam A, Samuel M, Tasman W. Combination intravitreal bevacizumab/panretinal photocoagulation versus panretinal photocoagulation alone in the treatment of neovascular glaucoma. Retina. 2008;28:696-702 pubmed publisher
    To evaluate same-day combination intravitreal bevacizumab/panretinal photocoagulation (PRP) for the treatment of neovascular glaucoma (NVG) compared with PRP alone.
  27. Eid T, Radwan A, el Manawy W, el Hawary I. Intravitreal bevacizumab and aqueous shunting surgery for neovascular glaucoma: safety and efficacy. Can J Ophthalmol. 2009;44:451-6 pubmed publisher
    To study the safety and efficacy of intravitreal injection of bevacizumab followed by aqueous shunting tube surgery for the management of neovascular glaucoma (NVG).
  28. Douat J, Auriol S, Mahieu Durringer L, Ancele E, Pagot Mathis V, Mathis A. [Intravitreal bevacizumab for treatment of neovascular glaucoma. Report of 20 cases]. J Fr Ophtalmol. 2009;32:652-63 pubmed publisher
    Bevacizumab is a recombinant humanised monoclonal antibody directed against the vascular endothelial growth factor (VEGF). We report the results of bevacizumab injections in the treatment of 20 cases of neovascular glaucoma.
  29. Bartz Schmidt K, Thumann G, Psichias A, Krieglstein G, Heimann K. Pars plana vitrectomy, endolaser coagulation of the retina and the ciliary body combined with silicone oil endotamponade in the treatment of uncontrolled neovascular glaucoma. Graefes Arch Clin Exp Ophthalmol. 1999;237:969-75 pubmed
    b>Neovascular glaucoma develops on a background of ischemic ocular pathologies, such as diabetic eye diseases or central retinal vein occlusion...
  30. Pokroy R, Greenwald Y, Pollack A, Bukelman A, Zalish M. Visual loss after transscleral diode laser cyclophotocoagulation for primary open-angle and neovascular glaucoma. Ophthalmic Surg Lasers Imaging. 2008;39:22-9 pubmed
    ..This study compared the treatment response in primary open-angle (POAG) and neovascular (NVG) glaucoma, particularly regarding vision loss...
  31. Grisanti S, Biester S, Peters S, Tatar O, Ziemssen F, Bartz Schmidt K. Intracameral bevacizumab for iris rubeosis. Am J Ophthalmol. 2006;142:158-60 pubmed
    To determine whether intracameral bevacizumab decreases vascular leakage from iris rubeosis in patients with neovascular glaucoma.
  32. Al Obeidan S, Osman E, Al Amro S, Kangave D, Abu el Asrar A. Full preoperative panretinal photocoagulation improves the outcome of trabeculectomy with mitomycin C for neovascular glaucoma. Eur J Ophthalmol. 2008;18:758-64 pubmed
    To investigate the efficacy of full panretinal photocoagulation (PRP) followed by trabeculectomy with mitomycin C (MMC) in the management of eyes with neovascular glaucoma (NVG).
  33. Faghihi H, Hajizadeh F, Mohammadi S, Kadkhoda A, Peyman G, Riazi Esfahani M. Pars plana Ahmed valve implant and vitrectomy in the management of neovascular glaucoma. Ophthalmic Surg Lasers Imaging. 2007;38:292-300 pubmed
    ..Rancho Cucamonga, CA) implant combined with pars plana vitrectomy and panretinal photocoagulation for the management of neovascular glaucoma in patients with vitreous hemorrhage.
  34. Lim T, Bae S, Cho Y, Lee J, Kim H, Sohn Y. Concentration of vascular endothelial growth factor after intracameral bevacizumab injection in eyes with neovascular glaucoma. Korean J Ophthalmol. 2009;23:188-92 pubmed publisher
    ..endothelial growth factor (VEGF) in the aqueous humor before and after intracameral injection of bevacizumab in eyes with neovascular glaucoma, and to detect the duration of an anti-VEGF effect of bevacizumab in the anterior chamber.
  35. Every S, Molteno A, Bevin T, Herbison P. Long-term results of Molteno implant insertion in cases of neovascular glaucoma. Arch Ophthalmol. 2006;124:355-60 pubmed
    To describe the long-term outcomes of cases of neovascular glaucoma drained by Molteno implants.
  36. Yucel I, Yucel G, Müftüoglu F. Plasma homocysteine levels in noninsulin-dependent diabetes mellitus with retinopathy and neovascular glaucoma. Int Ophthalmol. 2004;25:201-5 pubmed
    ..levels in noninsulin-dependent diabetes mellitus patients (NIDDM) with preproliferative retinopathy and neovascular glaucoma. The experimental goal was to determine the relationship between plasma homocysteine content and the ..
  37. Yazdani S, Hendi K, Pakravan M. Intravitreal bevacizumab (Avastin) injection for neovascular glaucoma. J Glaucoma. 2007;16:437-9 pubmed
    b>Neovascular glaucoma is a secondary glaucoma with grave prognosis which follows ischemic retinal disorders in the majority of cases...
  38. Moraczewski A, Lee R, Palmberg P, Rosenfeld P, Feuer W. Outcomes of treatment of neovascular glaucoma with intravitreal bevacizumab. Br J Ophthalmol. 2009;93:589-93 pubmed publisher
    To evaluate the course of treatment and outcomes of neovascular glaucoma (NVG) treated with intravitreal bevacizumab.
  39. Chen K, Wu C, Roy S, Lee S, Liu J. Increased interleukin-6 in aqueous humor of neovascular glaucoma. Invest Ophthalmol Vis Sci. 1999;40:2627-32 pubmed
    ..neovascularization by detecting the presence of interleukin (IL)-6, IL-2, and tumor necrosis factor (TNF)-alpha in aqueous humor and serum of patients with neovascular glaucoma (NVG) secondary to central retinal vein occlusion (CRVO).
  40. Leszczynski R, Domański R, Formińska Kapuścik M, Mrukwa Kominek E, Rokita Wala I. Contact transscleral cyclophotocoagulation in the treatment of neovascular glaucoma: a five-year follow-up. Med Sci Monit. 2009;15:BR84-7 pubmed
    The purpose of the study was to evaluate the long-term efficacy of contact transscleral cyclophotocoagulation (TSCPC) performed after panretinal photocoagulation and cryoapplication in patients with angle closure neovascular glaucoma.
  41. Vasudev D, Blair M, Galasso J, Kapur R, Vajaranant T. Intravitreal bevacizumab for neovascular glaucoma. J Ocul Pharmacol Ther. 2009;25:453-8 pubmed publisher
    To report 6-month and 1 year outcomes of eyes treated for neovascular glaucoma (NVG) with intravitreal bevacizumab injection and panretinal laser (PRP) compared to those receiving PRP alone.
  42. Shin J, Lee J, Sohn B, Kim H, Kim S. In vivo corneal endothelial safety of intracameral bevacizumab and effect in neovascular glaucoma combined with Ahmed valve implantation. J Glaucoma. 2009;18:589-94 pubmed publisher
    To evaluate the corneal toxicity of intracameral bevacizumab in rabbit eyes and also the effects of intracameral bevacizumab in neovascular glaucoma patients combined with Ahmed glaucoma valve implantation.
  43. Kahook M, Schuman J, Noecker R. Intravitreal bevacizumab in a patient with neovascular glaucoma. Ophthalmic Surg Lasers Imaging. 2006;37:144-6 pubmed
    The utility of intravitreal bevacizumab injection in a patient with neovascular glaucoma following central retinal vein occlusion is explored. Bevacizumab (1 mg in 0...
  44. Sugimoto Y, Mochizuki H, Okumichi H, Takumida M, Takamatsu M, Kawamata S, et al. Effect of intravitreal bevacizumab on iris vessels in neovascular glaucoma patients. Graefes Arch Clin Exp Ophthalmol. 2010;248:1601-9 pubmed publisher
    We aimed to investigate the effects of a single 1-mg injection of intravitreal bevacizumab on iris vessels in neovascular glaucoma (NVG) patients.
  45. Parodi M, Iacono P. Photodynamic therapy with verteporfin for anterior segment neovascularizations in neovascular glaucoma. Am J Ophthalmol. 2004;138:157-8 pubmed
    To evaluate photodynamic therapy (PDT) with verteporfin for iris and angle neovascularization in eyes with neovascular glaucoma.
  46. Ciftci S, Sakalar Y, Unlu K, Keklikci U, Caca I, Dogan E. Intravitreal bevacizumab combined with panretinal photocoagulation in the treatment of open angle neovascular glaucoma. Eur J Ophthalmol. 2009;19:1028-33 pubmed
    To evaluate the clinical efficacy of intravitreal bevacizumab (IVB) combined with panretinal photocoagulation in patients with open angle neovascular glaucoma (NVG).
  47. Kim Y, Hong S, Lee C, Kang S, Seong G, Ma K, et al. Level of vascular endothelial growth factor in aqueous humor and surgical results of ahmed glaucoma valve implantation in patients with neovascular glaucoma. J Glaucoma. 2009;18:443-7 pubmed publisher
    To determine the associations between the levels of growth factors in aqueous humor and the surgical outcomes of Ahmed glaucoma valve implantation in patients with neovascular glaucoma (NVG).
  48. Beutel J, Peters S, Lüke M, Aisenbrey S, Szurman P, Spitzer M, et al. Bevacizumab as adjuvant for neovascular glaucoma. Acta Ophthalmol. 2010;88:103-9 pubmed publisher
    We aimed to evaluate the longterm effects of intraocular bevacizumab (Avastin) injections as adjuvant treatment in patients with neovascular glaucoma.
  49. Chilov M, Grigg J, Playfair T. Bevacizumab (Avastin) for the treatment of neovascular glaucoma. Clin Exp Ophthalmol. 2007;35:494-6 pubmed
    ..Avastin appears to have a promising role in the treatment of neovascular glaucoma but is not without potential local and systemic side-effects.
  50. Martínez Carpio P, Bonafonte Márquez E, Heredia Garcia C, Bonafonte Royo S. [Efficacy and safety of intravitreal injection of bevacizumab in the treatment of neovascular glaucoma: systematic review]. Arch Soc Esp Oftalmol. 2008;83:579-88 pubmed
    Systematic review on efficacy and safety of intravitreal bevacizumab (IVB) in the treatment of neovascular glaucoma (NVG). All original papers published in Medline (prior to August 2008) were included.
  51. Gupta V, Jha R, Rao A, Kong G, Sihota R. The effect of different doses of intracameral bevacizumab on surgical outcomes of trabeculectomy for neovascular glaucoma. Eur J Ophthalmol. 2009;19:435-41 pubmed
    ..25 mg and 2.5 mg intracameral bevacizumab on surgical outcomes of trabeculectomy for neovascular glaucoma (NVG), with primary outcome measures being the regression of neovascularization of iris (NVI) and reduction ..
  52. Preda M, Davidescu L, Damian C, Irimia A, Sollosy M. [Neovascular glaucoma--prevention]. Oftalmologia. 2006;50:108-14 pubmed
    The aim of this paper is to analyse the incidence of neovascular glaucoma on a group of patients treated by laser photocoagulation for proliferative diabetic retinopathy and retinal vascular occlusions.
  53. Batioglu F, Astam N, Ozmert E. Rapid improvement of retinal and iris neovascularization after a single intravitreal bevacizumab injection in a patient with central retinal vein occlusion and neovascular glaucoma. Int Ophthalmol. 2008;28:59-61 pubmed
    ..to have anatomical and functional success in treating choroidal neovascularization, macular edema and neovascular glaucoma. We report a case with neovascular glaucoma due to central retinal vein occlusion who demonstrates rapid ..
  54. Gray A, Michels K, Lauer A, Samples J. Bartonella henselae infection associated with neuroretinitis, central retinal artery and vein occlusion, neovascular glaucoma, and severe vision loss. Am J Ophthalmol. 2004;137:187-9 pubmed
    ..To report a case of Bartonella henselae infection...
  55. Takihara Y, Inatani M, Fukushima M, Iwao K, Iwao M, Tanihara H. Trabeculectomy with mitomycin C for neovascular glaucoma: prognostic factors for surgical failure. Am J Ophthalmol. 2009;147:912-8, 918.e1 pubmed publisher
    To evaluate the prognostic factors for surgical outcomes of trabeculectomy with mitomycin C (MMC) for neovascular glaucoma (NVG).